The role of surface receptor stimulation on the cytotoxicity of resveratrol to macrophages

Food and Chemical Toxicology

Volumn 46, Issue 12, 2008, Pages 3664-3670

  Radkar, Vijayalaxmi ^a   Lau Cam, Cesar ^a   Hardej, Diane ^a   Billack, Blase ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Cell proliferation; Cell viability; Macrophages; Nitric oxide; Nitrite; Resveratrol; TLR4 ( )

Indexed keywords

NITRIC OXIDE; RESVERATROL; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN FUNCTION; RED WINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; CELL SURVIVAL; CULTURE MEDIA; DNA FRAGMENTATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICROSCOPY, ELECTRON, SCANNING; NITRITES; RECEPTORS, CELL SURFACE; STILBENES; TETRAZOLIUM SALTS; THIAZOLES; TOLL-LIKE RECEPTOR 4;

EID: 55949085476     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.09.043     Document Type: Article

References (61)

1. Ahmad A., Farhan Asad S., Singh S., and Hadi S.M. DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation. Cancer Lett. 154 (2000) 29-37
2. 115 at a pre-Golgi VTC stage. J. Cell Biol. 147 (1999) 1205-1222
3. Azios N.G., and Dharmawardhane S.F. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia 7 (2005) 128-140
4. Azmi A.S., Bhat S.H., Hanif S., and Hadi S.M. Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. FEBS Lett. 580 (2006) 533-538
5. Billack B., Heck D.E., Porterfield D.M., Malchow R.P., Smith P.J.S., Gardner C.R., Laskin D.L., and Laskin J.D. Minimal amidine structure for the inhibition of nitric oxide biosynthesis. Biochem. Pharmacol. 61 (2001) 1581-1586
6. Billack B., Heck D.E., Mariano T.M., Gardner C.R., Sur R., Laskin D.L., and Laskin J.D. Induction of cyclooxygenase-2 by heat shock protein 60 in macrophages and endothelial cells. Am. J. Physiol.- Cell Physiol. 283 (2002) L1267-1277
7. Billack B. Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B. Am. J. Pharm. Educ. 70 (2006) 102
8. Bruder J.L., Hsieh T., Lerea K.M., Olson S.C., and Wu J.M. Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. BMC Cell Biol. 2 (2001) 1
9. Cao Z., and Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 489 (2004) 39-48
10. Chan M.M., Mattiacci J.A., Hwang H.S., Shah A., and Fong D. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem. Pharmacol. 60 (2000) 1539-1548
11. Chávez E., Reyes-Gordillo K., Segovia J., Shibayama M., Tsutsumi V., Vergara P., Moreno M.G., and Muriel P. Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl(4) treatment in rats. J. Appl. Toxicol. 28 (2008) 35-43
12. Cho D.I., Koo N.Y., Chung W.J., Kim T.S., Ryu S.Y., Im S.Y., and Kim K.M. Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: Structural requirements and mechanism of action. Life Sci. 71 (2002) 2071-2082
13. Choi C., Cho H., Park J., Cho C., and Song Y. Suppressive effects of genistein on oxidative stress and NFkappaB activation in RAW 264.7 macrophages. Biosci. Biotechnol. Biochem. 67 (2003) 1916-1922
14. Crowell J.A., Korytko P.J., Morrissey R.L., Booth T.D., and Levine B.S. Resveratrol-associated renal toxicity. Toxicol. Sci. 82 (2004) 614-619
15. Das S., and Das D.K. Anti-inflammatory responses of resveratrol. Inflamm. Allergy Drug Targets 6 (2007) 168-173
16. Djoko B., Chiou R.Y., Shee J.J., and Liu Y.W. Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages. J. Agric. Food Chem. 55 (2007) 2376-2383
17. Donnelly L.E., Newton R., Kennedy G.E., Fenwick P.S., Leung R.H., Ito K., Russell R.E., and Barnes P.J. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L774-L783
18. Ekshyyan V.P., Hebert V.Y., Khandelwal A., and Dugas T.R. Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production. J Cardiovasc. Pharmacol. 50 (2007) 83-93
19. Ferry-Dumazet H., Garnier O., Mamani-Matsuda M., Vercauteren J., Belloc F., Billiard C., Dupouy M., Thiolat D., Kolb J.P., Marit G., Reiffers J., and Mossalayi M.D. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23 (2002) 1327-1333
20. Hassan F., Islam S., Mu M.M., Ito H., Koide N., Mori I., Yoshida T., and Yokochi T. Lipopolysaccharide prevents doxorubicin-induced apoptosis in RAW 264.7 macrophage cells by inhibiting p53 activation. Mol. Cancer Res. 3 (2005) 373-379
21. Hebbar V., Shen G., Hu R., Kim B.R., Chen C., Korytko P.J., Crowell J.A., Levine B.S., and Kong A.N. Toxicogenomics of resveratrol in rat liver. Life Sci. 76 (2005) 2299-2314
22. Holian O., Wahid S., Atten M.J., and Attar B.M. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G809-G816
23. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162 (1999) 3749-3752
24. Hung L.M., Chen J.K., Huang S.S., Lee R.S., and Su M.J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47 (2000) 549-555
25. Islam S., Hassan F., Mu M.M., Ito H., Koide N., Mori I., Yoshida T., and Yokochi T. Piceatannol prevents lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-kappaB activation by inhibiting IkappaB kinase (IKK). Microbiol. Immunol. 48 (2004) 729-736
26. Islam S., Hassan F., Tumurkhuu G., Ito H., Koide N., Mori I., Yoshida T., and Yokochi T. Lipopolysaccharide prevents apoptosis induced by brefeldin A, an endoplasmic reticulum stress agent, in RAW 264.7 cells. Biochem. Biophys. Res. Commun. 340 (2006) 589-596
27. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
28. Jang D.S., Kang B.S., Ryu S.Y., Chang I.M., Min K.R., and Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem. Pharmacol. 57 (1999) 705-712
29. Jang M., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Drugs Exp. Clin. Res. 25 (1999) 65-77
30. Joe A.K., Liu H., Suzui M., Vural M.E., Xiao D., and Weinstein I.B. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8 (2002) 893-903
31. Jung H.J., Seu Y.B., and Lee D.G. Candicidal action of resveratrol isolated from grapes on human pathogenic yeast C Albicans. J. Microbiol. Biotechnol. 17 (2007) 1324-1329
32. Kim Y.A., Kim G.Y., Park K.Y., and Choi Y.H. Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia. J. Med. Food. 10 (2007) 218-224
33. Laskin D.L., and Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 655-677
34. Leikert J.F., Räthel T.R., Wohlfart P., Cheynier V., Vollmar A.M., and Dirsch V.M. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106 (2002) 1614-1617
35. Li X., and Stark G.R. NFkappaB-dependent signaling pathways. Exp. Hematol. 30 (2002) 285-296
36. Lombardo E., Alvarez-Barrientos A., Maroto B., Bosca L., and Knaus U.G. TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-alpha autocrine signalling. J. Immunol. 178 (2007) 3731-3739
37. Lorenz E., Patel D.D., Hartung T., and Schwartz D.A. Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of bacteroides fragilis lipopolysaccharide. Infect. Immun. 70 (2002) 4892-4896
38. Luzi C., Brisdelli F., Cinque B., Cifone G., and Bozzi A. Differential sensitivity to resveratrol-induced apoptosis of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells. Biochem. Pharmacol. 68 (2004) 2019-2030
39. Manna S.K., Mukhopadhyay A., and Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164 (2000) 6509-6519
40. Means T.K., Lien E., Yoshimura A., Wang S., Golenbock D.T., and Fenton M.J. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for toll-like receptors. J. Immunol. 163 (1999) 6748-6755
41. Meng Y., Ma Q.Y., Kou X.P., and Xu J. Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatitis. World J. Gastroenterol. 11 (2005) 525-528
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
43. Notas G., Nifli A.P., Kampa M., Vercauteren J., Kouroumalis E., and Castanas E. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim. Biophys. Acta 1760 (2006) 1657-1666
44. Orallo F., Alvarez E., Camiña M., Leiro J.M., Gómez E., and Fernández P. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 61 (2002) 294-302
45. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
46. Radkar V., Hardej D., Lau-Cam C., and Billack B. Evaluation of resveratrol and piceatannol cytotoxicity in macrophages, T cells, and skin cells. Arh. Hig. Rad. Toksikol. 58 (2007) 293-304
47. Raetz C.R., and Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71 (2002) 635-700
48. Romagne F. Current and future drugs targeting one class of innate immunity receptors: the toll-like receptors. Drug Discov. Today 12 (2007) 80-87
49. Schmitt E., Lehmann L., Metzler M., and Stopper H. Hormonal and genotoxic activity of resveratrol. Toxicol. Lett. 136 (2002) 133-142
50. Schuster J.M., and Nelson P.S. Toll receptors: an expanding role in our understanding of human disease. J. Leukoc. Biol. 67 (2000) 767-773
51. Shah Y.M., Al-Dhaheri M., Dong Y., Ip C., Jones F.E., and Rowan B.G. Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Mol. Cancer. Ther. 4 (2005) 1239-1249
52. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
53. Stervbo U., Vang O., and Bonnesen C. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif. 39 (2006) 479-493
54. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., and Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273 (1998) 21875-21882
55. Surh Y.J., Hurh Y.J., Kang J.Y., Lee E., Kong G., and Lee S.J. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140 (1999) 1-10
56. Szewczuk L.M., Forti L., Stivala L.A., and Penning T.M. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J. Biol. Chem. 279 (2004) 22727-22737
57. Szmitko P.E., and Verma S. Cardiology patient pages. Red wine and your heart. Circulation 111 (2005) e10-e11
58. Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126 (1999) 673-680
59. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M., and Aderem A. The toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401 (1999) 811-815
60. Wadsworth T.L., and Koop D.R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol. 57 (1999) 941-949
61. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., and Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106 (2002) 1652-1658